Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
We Can Medicines CoROCO:6929 -0.45%46 Days Payable is 82.88 as of Dec. 2025, which is 0% above its 10-year median of 82.48. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,889 Consumer Packaged Goods companies, We Can Medicines Co ranks better than 78.08% on this metric.
The historical rank and industry rank for We Can Medicines Co's Days Payable or its related term are showing as below:
ROCO:6929'
s Days Payable Range Over the Past 10 Years
Min: 57.38 Med: 82.48 Max: 91.18
Current: 84.04
During the past 6 years, We Can Medicines Co's highest Days Payable was 91.18. The lowest was 57.38. And the median was 82.48.
ROCO:6929's Days Payable is ranked better than 78.08% of 1889
companies
in the Consumer Packaged Goods industry
Industry Median: 44.15
vs ROCO:6929: 84.04
We Can Medicines Co's Days Payable
increased
from Dec. 2024 (82.45) to Dec. 2025 (82.88).
It may suggest that We Can Medicines Codelayed paying its suppliers.
We Can Medicines Co Days Payable Related Terms
We Can Medicines Co Days Payable Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, We Can Medicines Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Days Payable distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
We Can Medicines Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
We Can Medicines Co (ROCO:6929) has a Days Payable of 82.88 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on We Can Medicines Co and its competitors. This is near median its historical median of 82.48. Over the past decade, We Can Medicines Co's Days Payable has ranged from 57.38 to 91.18. According to the industry distribution chart, We Can Medicines Co ranks #414 out of 1889 companies in the Consumer Packaged Goods industry, placing it in the top 21.9%.
Is We Can Medicines Co's Days Payable too high?
We Can Medicines Co's current Days Payable of 82.88 is near median its 10-year median of 82.48. Over the past 10 years, this metric has ranged from a low of 57.38 to a high of 91.18. The Consumer Packaged Goods industry median Days Payable is 44.15. We Can Medicines Co's value of 82.88 is 87.7% above this industry median. Based on the distribution chart, We Can Medicines Co ranks #414 out of 1889 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #414 out of 1889 companies for Days Payable. This places We Can Medicines Co in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.15. We Can Medicines Co's value of 82.88 is 87.7% above this benchmark. Historically, We Can Medicines Co's own Days Payable has ranged from 57.38 to 91.18 over the past decade. While the company's 10-year median is 82.48 vs. the industry median of 44.15, We Can Medicines Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,889 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. We Can Medicines Co's current Days Payable of 82.88 is 87.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current Days Payable is 82.88, which is near median its own 10-year median of 82.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current Days Payable is 82.88, which is near median its 10-year median of 82.48 and 87.7% above the Consumer Packaged Goods industry median of 44.15. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current Days Payable is 82.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
Days Payable: 82.88 (near median its 10-year median of 82.48)
GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
Industry Position: 87.7% above the Consumer Packaged Goods median (#414 of 1889)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
